Thursday 19 November 2026 Sign in / SubscribeFree daily emailMarket analysisEnterprise solutionsVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Manufacturing & supply

FDA files Class II recall of Victory Medical Center Pharmacy B complex

A 30ml B complex product from the pharmacy is subject to an open recall in Colorado, Florida and Texas, though the size of the commercial exposure is not disclosed.

11 Nov 2026 · FDA enforcement report · Regulator

The commercial weight of a new US drug recall depends on volume, lots and the length of the supply chain affected. For the Victory Medical Center Pharmacy action, the public record gives none of that, so any financial or supply impact cannot be sized.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on CompePharma and VigiEye
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official record: FDA enforcement report ↗

Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.

More Manufacturing & supplyAll →